Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | January 22, 2025 |
| PDB ID | UniProt ID | Title ▼ | Descriptor |
|---|---|---|---|
| 7Q3Q | A0A6H2EIN2 | Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobody VHH-12 | |
| 7Q3Q | 7Q3Q | Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobody VHH-12 | |
| 7Q3R | A0A6H2EIN2 | Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobodies VHH-F04 and VHH-G09 | |
| 7Q3R | 7Q3R | Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobodies VHH-F04 and VHH-G09 | |
| 7UL1 | P0DTC2 | Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing IGHV3-53-encoded antibody EH3 isolated from a nonvaccinated pediatric patient | |
| 7UL1 | 7UL1 | Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing IGHV3-53-encoded antibody EH3 isolated from a nonvaccinated pediatric patient | |
| 7E5O | P0DTC2 | Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193 | |
| 7E5O | 7E5O | Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193 | |
| 7VOA | 7VOA | Crystal structure of SARS-CoV-2 RBD in complex with aRBD5 | |
| 7VOA | P0DTC2 | Crystal structure of SARS-CoV-2 RBD in complex with aRBD5 | |
| 7DET | P0DTC2 | Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv | |
| 7DET | 7DET | Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv | |
| 7DEU | P0DTC2 | Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv | |
| 7DEU | 7DEU | Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv | |
| 7DEO | 7DEO | Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv | |
| 7DEO | P0DTC2 | Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv | |
| 7CJF | 7CJF | Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody Fab | |
| 7CJF | P0DTC2 | Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody Fab | |
| 7KM5 | P0DTC2 | Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1 | |
| 7KM5 | 7KM5 | Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1 | |
| 7DHX | 7DHX | Crystal structure of SARS-CoV-2 RBD binding to pangolin ACE2 | |
| 7DHX | P0DTC2 | Crystal structure of SARS-CoV-2 RBD binding to pangolin ACE2 | |
| 7E3J | 7E3J | Crystal structure of SARS-CoV-2 RBD binding to dog ACE2 | |
| 7E3J | P0DTC2 | Crystal structure of SARS-CoV-2 RBD binding to dog ACE2 | |
| 7FC5 | F6V9L3 | Crystal structure of SARS-CoV-2 RBD and horse ACE2 | |
| 7FC5 | P0DTC2 | Crystal structure of SARS-CoV-2 RBD and horse ACE2 | |
| 8HES | P0DTC2 | Crystal structure of SARS-CoV-2 RBD and NIV-10 complex | |
| 8HES | 8HES | Crystal structure of SARS-CoV-2 RBD and NIV-10 complex | |
| 7P19 | Q9BYF1 | Crystal structure of SARS-CoV-2 RBD Q498Y complexed with human ACE2 | |
| 7P19 | P0DTC2 | Crystal structure of SARS-CoV-2 RBD Q498Y complexed with human ACE2 | |
| 7WSK | Q56NL1 | Crystal structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with civet ACE2 | |
| 7WSK | P0DTC2 | Crystal structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with civet ACE2 | |
| 7FJC | P0DTC2 | Crystal structure of SARS-CoV-2 Beta RBD complexed with P36-5D2 Fab | |
| 7FJC | 7FJC | Crystal structure of SARS-CoV-2 Beta RBD complexed with P36-5D2 Fab | |
| 8GB8 | P0DTC2 | Crystal structure of SARS-CoV-2 BA.2 receptor binding domain in complex with neutralizing antibody 20A7 | |
| 8GB8 | 8GB8 | Crystal structure of SARS-CoV-2 BA.2 receptor binding domain in complex with neutralizing antibody 20A7 | |
| 7S5P | P0DTC2 | Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibody CS23 | |
| 7S5P | 7S5P | Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibody CS23 | |
| 7S5Q | P0DTC2 | Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibodies CS44 and COVA1-16 | |
| 7S5Q | 7S5Q | Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibodies CS44 and COVA1-16 | |
| 8WCG | P59594 | Crystal structure of SARS-CoV-1 RBD in complex with nanobody aSR29 and aSR347 | |
| 8WCG | 8WCG | Crystal structure of SARS-CoV-1 RBD in complex with nanobody aSR29 and aSR347 | |
| 7LM9 | D2E265 | Crystal structure of SARS-CoV spike protein receptor-binding domain in complex with a cross-neutralizing antibody CV38-142 Fab isolated from COVID-19 patient | |
| 7LM9 | 7LM9 | Crystal structure of SARS-CoV spike protein receptor-binding domain in complex with a cross-neutralizing antibody CV38-142 Fab isolated from COVID-19 patient | |
| 7JN5 | Q19QX0 | Crystal structure of SARS-CoV receptor binding domain in complex with human antibody CR3022 | |
| 7JN5 | 7JN5 | Crystal structure of SARS-CoV receptor binding domain in complex with human antibody CR3022 | |
| 7Y3N | P59594 | Crystal structure of SARS-CoV receptor binding domain in complex with human antibody BIOLS56 | |
| 7Y3N | 7Y3N | Crystal structure of SARS-CoV receptor binding domain in complex with human antibody BIOLS56 | |
| 7FC6 | F6V9L3 | Crystal structure of SARS-CoV RBD and horse ACE2 | |
| 7FC6 | P59594 | Crystal structure of SARS-CoV RBD and horse ACE2 |
